Search Results
Aug 11, 2026, 11:19 ET H+H International A/S: Interim Financial Report, H1 2026
https://news.cision.com/h-h-international-a-s/r/interim-financial-report--h1-2026,c4382157The following files are available for download:
More news about: H+H International A/S
Aug 11, 2026, 11:09 ET Scott Speed and Subaru WRX: Project Midnight Set New Mount Washington Hillclimb Record
R53 Suspension, Triple-R Lights,
More news about: Subaru of America, Inc.
Aug 11, 2026, 11:08 ET Kingstone Capital AG (Suisse) met fin à sa coentreprise avec Versorgungswerk der Zahnärzte Berlin (VZB)
durable. Cependant, les événements de ces derniers mois ont montré qu'il n'était plus possible de poursuivre ce partenariat », a déclaré Martin R. Smura, fondateur du Grand Metropolitan Hotels Group.Selon l'entreprise, la coentreprise se trouvait dans une impasse prolongée après que plusieurs
More news about: Grand Metropolitan Hotels
Aug 11, 2026, 11:06 ET "Crossing the 49th Parallel" -- the Cross-Border Retirement Guide -- Arrives on Audible
Narrated by Mateus R. Gomes and running 4 hours and 41 minutes, the audiobook covers the decisions that define financial life across the 49th parallel: what happens to RRSPs,
More news about: Lucas Wennersten
Aug 11, 2026, 11:00 ET Exer AI Announces Exer Scan App's Hand/Wrist Module Introduced at Mayo Clinic to Advance Musculoskeletal Care and Clinical Workflow Efficiency
patients' lives and providers' decision-making across complex care needs in multiple specialities, including orthopedics, neurology, pain/spine, PM&R, geriatrics, and more.Media [email protected] Clinic
More news about: Exer AI
Aug 11, 2026, 10:07 ET The Gross Law Firm Reminds Microsoft Corporation Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2026 - MSFT
its profitable Azure services in order to improve the competitive positioning of its critical Copilot family of products and increase its AI-related R&D; and (d) as a result of (a)-(c) above, Microsoft had failed to convert a significant percentage of its commercial Microsoft 365 users to paid Copilot
More news about: The Gross Law Firm
Aug 11, 2026, 10:03 ET Graduate Enrollment Enters the AI Operationalization Era as Eight Leading Universities Deploy ReadyRecruit
nationally respected SEC land-grant university with nationally recognized engineering and business programs.Premier Northwest R1 — A leading Pacific Northwest research university with nationally recognized graduate business programs.Health Sciences
More news about: GPRS
Aug 11, 2026, 10:00 ET Itaúsa posts record recurring net income of R$8.8 billion in 1H26, up 12%
content:https://www.prnewswire.co.uk/news-releases/itausa-posts-record-recurring-net-income-of-r8-8-billion-in-1h26--up-12-302848419.html
More news about: Itaúsa
Aug 11, 2026, 10:00 ET Itaúsa posts record recurring net income of R$8.8 billion in 1H26, up 12%
content:https://www.prnewswire.com/news-releases/itausa-posts-record-recurring-net-income-of-r8-8-billion-in-1h26--up-12-302848418.htmlSOURCE
More news about: Itaúsa
Aug 11, 2026, 09:32 ET In HelloNation, HVAC Expert Greg Carlson Discusses What to Consider When Choosing an HVAC Maintenance Plan
A HelloNation article answers that question through insights from HVAC Expert Greg Carlson of R. L. Lyon Inc. Heating & A.C. in Morris, IL.The HelloNation article explains that selecting an HVAC maintenance plan involves more than comparing
More news about: HelloNation
Aug 11, 2026, 09:30 ET R-Zero Expands Its Physical AI Platform with Continuous Building Savings
about Continuous Building Savings, visit rzero.com/cbsAbout R-ZeroR-Zero is the Physical AI platform for buildings. By combining real-time occupancy intelligence, existing building systems, and environmental data, R-Zero creates a continuously updated understanding of how commercial
More news about: R-Zero
Aug 11, 2026, 09:05 ET FAU Video Compression Technology Portfolio Acquired by Dolby Laboratories
R1: Very High Research Spending and Doctorate Production,
More news about: Florida Atlantic University
Aug 11, 2026, 09:00 ET DUDE Wipes Appoints Steve Winchell as First-Ever Chief Product DUDE, Marking Company's First C-Suite Executive Hire Since Founding
experience leading innovation, R&D, product commercialization and operations for some of the world's most recognizable consumer brands. Most recently, he served as Executive Vice President and Chief Innovation Officer at The Honest Company, where he led R&D, Supply Chain and Technology while
More news about: DUDE Wipes
Aug 11, 2026, 09:00 ET Ember LifeSciences appoints James Braithwaite as Chief Product Officer
"James is one of the most accomplished R&D and product development executives in the country," said Clay Alexander, founder and CEO of Ember LifeSciences. "He brings a proven track record of
More news about: Ember LifeSciences
Aug 11, 2026, 09:00 ET Metabolon Launches Peak Science Grant Program to Advance Breakthrough Metabolomics Research
and demonstrate a creative or novel use of metabolomics. All applications will be reviewed by a panel of senior scientific leaders from Metabolon's R&D, lab operations, and Discovery & Translational Sciences teams.The submission deadline for the current quarter is September 30, 2026, and
More news about: Metabolon, Inc.
Aug 11, 2026, 09:00 ET Metabolon Launches Peak Science Grant Program to Advance Breakthrough Metabolomics Research
and demonstrate a creative or novel use of metabolomics. All applications will be reviewed by a panel of senior scientific leaders from Metabolon's R&D, lab operations, and Discovery & Translational Sciences teams.The submission deadline for the current quarter is September 30, 2026, and
More news about: Metabolon, Inc.
Aug 11, 2026, 09:00 ET Norm Ai and Norm Law Open Washington, D.C. Office as Norm Law Welcomes Partners Katelyn Kimber and Lindsey Savage
raised more than $260 million from Khosla Ventures, Craft Ventures, Bain Capital Ventures, Coatue, Blackstone, Vanguard, Citi, New York Life, TIAA, Henry R. Kravis, and Marc Benioff. For more information, visit
More news about: Norm Law
Aug 11, 2026, 09:00 ET 10 Finalist Teams Awarded $1M to Advance in XPRIZE Healthspan $101 Million Race to Transform Healthy Aging
ambitious ideas are matched with rigorous evidence and strong collaboration," said Dr. Kaivan Khavandi, SVP, Head of Respiratory & Immunology R&D, GSK. "XPRIZE Healthspan is creating an environment where innovators can test promising approaches against a common scientific standard, accelerating
More news about: XPRIZE
Aug 11, 2026, 08:31 ET Ceramedix Awarded Up to $4.5 Million NIAID Contract to Advance Lead GI-ARS Therapeutic Toward IND Submission
The award enables Ceramedix to build upon its work under contract number 75N93023C00015 and SBIR Phase 2b grant number 5R44AI106283-08, from NIAID. The new contract will fund essential activities needed to support the submission of an Investigational New Drug (IND) application
More news about: Ceramedix, Inc.
Aug 11, 2026, 08:30 ET FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets
its business; (b) expectations regarding the initiation, progress and expected results of FibroBiologics' R&D efforts and preclinical studies; (c) the unpredictable relationship between R&D and preclinical results and clinical study results; and (d) the ability of FibroBiologics to successfully
More news about: FibroBiologics, Inc.
Aug 11, 2026, 08:00 ET Kalohexis Appoints Life Sciences Leader, Jeffrey Sherman, MD, to Board of Directors
central melanocortin-3 and -4 receptors (MC3R/MC4R) to treat many metabolic disorders. Kalohexis' lead pipeline programs are 710GO, an oral dual MC3R/MC4R agonist to induce healthier, more durable weight loss in general obesity, and mifomelatide, a dual MC3R/MC4R antagonist to treat cachexia in patients
More news about: Kalohexis
Aug 11, 2026, 08:00 ET Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
world rights Mereo will receive an upfront option fee and, on option exercise, is eligible to receive up to $40 million in upfront and R&D payments until NDA filing, and double-digit tiered royalties on U.S. salesCompanies will collaborate to refine the Phase 3 design during
More news about: Sentynl Therapeutics
Aug 11, 2026, 08:00 ET Novo Nordisk's Awiqli®, the first once-weekly basal insulin for adults with type 2 diabetes, now available in the US
years, Novo Nordisk US is headquartered in New Jersey and employs approximately 10,000 people throughout the country across more than 10 manufacturing, R&D and corporate locations in seven states plus Washington DC. For more information, visit
More news about: Novo Nordisk